Sudarshan Chemical Industries Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
SUDARSCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sudarshan Chemical Industries reported strong standalone performance with revenue of Rs 2,396.7 crore (down 5.4% YoY) but PAT surged 106% to Rs 290.3 crore driven by foreign exchange gains of Rs 115.6 crore and lower material costs. Consolidated revenue jumped 193% to Rs 9,787.2 crore due to Heubach acquisition (completed March 2025), though consolidated PAT declined 32% to Rs 40.8 crore due to integration costs of Rs 135.2 crore. The company recommended a 250% dividend (Rs 5 per share). Appointed PwC Services LLP as internal auditor for FY27.
Standalone earnings beat expectations with 106% PAT growth, but the stock faces consolidation complexity from Heubach integration costs and declining consolidated profitability. The large foreign exchange gains and improved margins are positives, though sustainability of these factors needs monitoring.